Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra.

Paris, Irmgard

Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra. [electronic resource] - Journal of neurochemistry Mar 2005 - 1021-32 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

0022-3042

10.1111/j.1471-4159.2004.02931.x doi


Adrenergic Uptake Inhibitors--pharmacology
Analysis of Variance
Animals
Catecholamine Plasma Membrane Transport Proteins
Cell Death--drug effects
Cells, Cultured
Chlorides--metabolism
Dicumarol--pharmacology
Dopamine--metabolism
Dopamine Plasma Membrane Transport Proteins
Dopamine Uptake Inhibitors
Dose-Response Relationship, Drug
Electron Spin Resonance Spectroscopy--methods
Embryo, Mammalian
Enzyme Inhibitors--pharmacology
Ferric Compounds--metabolism
Fluorescent Antibody Technique--methods
Imipramine--pharmacology
Indolequinones--pharmacology
Iron--toxicity
Iron Isotopes--pharmacology
Membrane Glycoproteins--metabolism
Membrane Transport Modulators
Membrane Transport Proteins--antagonists & inhibitors
Microscopy, Confocal--methods
Models, Biological
Morpholines--pharmacology
Nerve Tissue Proteins--metabolism
Neurons--drug effects
Nomifensine--pharmacology
Norepinephrine--pharmacology
Norepinephrine Plasma Membrane Transport Proteins
Rats
Rats, Inbred F344
Rats, Wistar
Reboxetine
Serotonin Plasma Membrane Transport Proteins
Sodium--metabolism
Substantia Nigra--cytology
Symporters--metabolism
Thiobarbituric Acid Reactive Substances--metabolism
Tyrosine 3-Monooxygenase--metabolism